Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner (Q83380976)
Jump to navigation
Jump to search
scientific article published on 25 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner |
scientific article published on 25 January 2012 |
Statements
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner (English)
Andrea Mencarelli
Daniela Francisci
Barbara Renga
Sabrina Cipriani
Flavia Basile
Elisabetta Schiaroli
Franco Baldelli
Stefano Fiorucci
25 January 2012